Spire Healthcare Group PLC with ticker (LON:SPI) now has a potential upside of 15.1% according to RBC Capital Markets.
RBC Capital Markets set a target price of 260 GBX for the company, which when compared to the Spire Healthcare Group PLC share price of 226 GBX at opening today (22/11/2023) indicates a potential upside of 15.1%. Trading has ranged between 202 (52 week low) and 253 (52 week high) with an average of 458,075 shares exchanging hands daily. The market capitalisation at the time of writing is £913,324,534.
Spire Healthcare Group plc is a United Kingdom-based company that owns and operates private hospitals and clinics in the United Kingdom (UK) and provides a range of private healthcare services. The Company offers a range of treatments and services, such as allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, dental surgery, eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, heart treatments, neurosurgery and neurology, hip and knee, kidney treatments, physiotherapy, podiatry, respiratory medicine, scans and investigations, skin treatments, spinal surgery and treatments, sports science, vascular surgery, weight loss, women’s health, and others. Its tests and scans include cardiac computerized tomography (CT), CT scans, magnetic resonance imaging (MRI) scans, ultrasound scans, and x-rays.
Spire Healthcare Group PLC 15.1% potential upside indicated by RBC Capital Markets
- Written by: Charlotte Edwards
Latest Company News
Spire Healthcare will announce interim results for the six months ended 30 June 2026 on 9 September 2026.
Spire Healthcare has announced that Sir Ian Cheshire will step down as Chair by 30 September 2026 and Debbie White will succeed him.
Spire Healthcare says discussions with Toscafund continue, with the Takeover Panel consenting to a further extension of the offer deadline.
Spire Healthcare said trading for the first four months of 2026 was in line with expectations, with strong private patient revenue growth and FY26 adjusted EBITDA still targeted broadly in line with FY25.
EDX Medical Group has partnered with Spire Healthcare to enhance digital diagnostics for cancer and other diseases, promising innovative patient care and improved outcomes.
Spire Healthcare Group has acquired Acorn Occupational Health for £3.3 million, enhancing its Primary Care Services and expanding its occupational health capabilities.
